By Sneha S K and Puyaan Singh (Reuters) -Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's ...

Hims & Hers Health shares jumped Tuesday as the company added Eli Lilly’s weight-loss drug Zepbound and diabetes treatment ...

Relatively inexpensive and accessible self-management interventions to help people manage type 2 diabetes have been found to ...

When you have diabetes, eating sweets can be like navigating a minefield. While low-sugar substitutes do exist for ice creams ...

A new study finds that microplastics seem to contribute to more chronic diseases in coastal areas of the United States. Rates of stroke, high blood pressure and diabetes are higher in coastal or ...

A new study found that spending on GLP-1 medications such as Ozempic, Wegovy and Zepbound surged to $5.8 billion in 2022 ...

Discover 5 kid-approved diabetic-friendly cookie recipes that satisfy sweet cravings without blood sugar spikes, plus expert ...

Combination treatment with a GLP-1 agonist and thiazolidinedione in type 2 diabetes was tied to a significantly lower risk of ...

Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...

Aubrie Lewis said her son is asymptomatic to blood sugar highs and lows, so she has "learned to trust Ducky" and listens to him.

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.

Learn about the 4 essential types of diabetes, their unique characteristics, risk factors, and management strategies to ...